Berry Janice E, Zhao Ming, Jin Qiming, Foster Brian L, Viswanathan Hema, Somerman Martha J
Department of Periodontics/Prevention/Geriatrics, School of Dentistry, University of Michigan, Ann Arbor, Michigan 48109-1078, USA.
Connect Tissue Res. 2003;44 Suppl 1:97-102.
Future directions for designing periodontal regenerative therapies hinge on characterization of cells associated with periodontal tissues and on signals instrumental in regulating their behavior. Studies here focused on determining the responsiveness of putative cementoblast progenitor cells (follicle cells), periodontal ligament cells, and cementoblasts to specific factors. Cementoblasts (OCCM), periodontal ligament (SVPDL) cells, and follicle cells (SVF4) were isolated from mouse tissues and immortalized, where SV indicates the use of SV-40 for immortalization. Cultured cells were examined for response to parathyroid hormone-related protein (PTHrP), bone morphogenetic protein-2 (BMP-2), and enamel matrix derivative (EMD) using RT-PCR, Northern analysis, and in vitro and in vivo mineralization assays. Results showed that the three cell lines varied in their expression of bone sialoprotein (BSP) and osteocalcin (OCN), and in their capacity to promote mineralization. RT-PCR indicated that all cell lines had PTH/PTHrP-R1 and BMP receptors; however, the response of individual cell lines to PTHrP, BMP-2, and EMD was quite different. Such dissimilarities in responsiveness associated with cell type may need to be considered when designing regenerative therapies.
设计牙周再生疗法的未来方向取决于对牙周组织相关细胞的特性描述以及对调节其行为起重要作用的信号。这里的研究集中于确定假定的成牙骨质细胞祖细胞(滤泡细胞)、牙周膜细胞和成牙骨质细胞对特定因子的反应性。从小鼠组织中分离出成牙骨质细胞(OCCM)、牙周膜(SVPDL)细胞和滤泡细胞(SVF4)并使其永生化,其中SV表示使用SV-40进行永生化。使用逆转录聚合酶链反应(RT-PCR)、Northern印迹分析以及体外和体内矿化试验,检测培养的细胞对甲状旁腺激素相关蛋白(PTHrP)、骨形态发生蛋白-2(BMP-2)和釉基质衍生物(EMD)的反应。结果显示,这三种细胞系在骨唾液蛋白(BSP)和骨钙素(OCN)的表达以及促进矿化的能力方面存在差异。RT-PCR表明所有细胞系都有甲状旁腺激素/甲状旁腺激素相关蛋白受体1(PTH/PTHrP-R1)和骨形态发生蛋白受体;然而,各个细胞系对PTHrP、BMP-2和EMD的反应差异很大。在设计再生疗法时,可能需要考虑与细胞类型相关的这种反应性差异。